Possibia

6467370

Last Update Posted: 2025-02-07

Recruiting has ended

All Genders

accepted

18 Years +

375 Estimated Participants

No Expanded Access

Observational Study

Accepts healthy volunteers

A Real-world, Prospective Observational Study of Rimegepant ODT for the Acute Treatment of Migraine Attacks in Adults.

This study aims at characterizing the effectiveness of rimegepant as an acute migraine treatment in a real world setting on two aspects:

  • Consistency of response to rimegepant across multiple attacks
  • Effectiveness of rimegepant in users taking concomitant migraine preventive medications, namely monoclonal antibodies targeting CGRP and onabotulinumtoxinA

This study aims at characterizing the effectiveness of rimegepant as an acute migraine treatment in a real world setting on two aspects:

  • Consistency of response to rimegepant across multiple attacks
  • Effectiveness of rimegepant in users taking concomitant migraine preventive medications, namely monoclonal antibodies targeting CGRP and onabotulinumtoxinA

Eligibility

Relevant conditions:

Migraine

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Data sourced from ClinicalTrials.gov